ASP2151
Showing 1 - 13 of 13
Healthy Trial in London (ASP2151 400mg + 100mg ciclosporin, ASP2151 1200mg + 100mg ciclosporin)
Completed
- Healthy
- ASP2151 400mg + 100mg ciclosporin
- ASP2151 1200mg + 100mg ciclosporin
-
London, United KingdomHammersmith Medicines Research Ltd
Jan 31, 2019
Healthy Trial in London (Montelukast, ASP2151)
Completed
- Healthy
- Montelukast
- ASP2151
-
London, United KingdomHammersmith Medicines Research Ltd
Feb 25, 2019
Healthy Trial in London (Bupropion, ASP2151)
Completed
- Healthy
- Bupropion
- ASP2151
-
London, United KingdomHammersmith Medicines Research Ltd
Jan 31, 2019
Healthy Trial in London (ASP2151, ritonavir)
Completed
- Healthy
- ASP2151
- ritonavir
-
London, United KingdomHammersmith Medicines Research Ltd
Feb 25, 2019
Healthy Trial in London (Midazolam, ASP2151)
Completed
- Healthy
- Midazolam
- ASP2151
-
London, United KingdomHammersmith Medicines Research Ltd
Jan 31, 2019
Herpes Zoster Trial in Sapporo, Yokohama, Nakano-Ku (ASP2151, valaciclovir)
Herpes Zoster Trial in Japan (ASP2151, Valacyclovir HCl)
Completed
- Herpes Zoster
- ASP2151
- Valacyclovir hydrochloride
-
Chubu, Japan
- +4 more
Nov 20, 2018
Herpes Genitalis Trial in United States (ASP2151, valacyclovir, Placebo)
Completed
- Herpes Genitalis
- ASP2151
- +2 more
-
Birmingham, Alabama
- +24 more
Dec 1, 2017
Healthy Subjects Trial in Osaka (ASP2151, Placebo)
Completed
- Healthy Subjects
- ASP2151
- Placebo
-
Osaka, JapanSite JP00001
Aug 25, 2016
Herpes Simplex Trial in Sapporo, Yokohama, Nakano-ku (ASP2151, ASP2151 )
Completed
- Herpes Simplex
- ASP2151
- ASP2151 placebo
-
Sapporo, Hokkaido, Japan
- +2 more
Mar 15, 2016
Herpes Simplex Trial in Sapporo, Tokyo, Yokohama (ASP2151)
Completed
- Herpes Simplex
- ASP2151
-
Sapporo, Japan
- +2 more
Mar 15, 2016
Safety of ASP2151 Trial in United States (ASP2151, Valacyclovir, Placebo)
Terminated
- Safety of ASP2151
- ASP2151
- +2 more
-
Daytona Beach, Florida
- +4 more
Feb 27, 2013